Safety Study of Oral MGCD265 Administered With Interruption to Subjects With Advanced Malignancies
Clinical trial NCT00679133 · COMPLETED
Trial details
- NCT number
- NCT00679133
- Sponsor
- Mirati Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-04-01
- Primary completion
- 2011-03-01
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.